The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus.
about
Cancer and comorbidity: redefining chronic diseasesDefining comorbidity: implications for understanding health and health servicesHematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCTFactors that predict outcome of intensive care treatment in very elderly patients: a review.Subjective assessments of comorbidity correlate with quality of life health outcomes: initial validation of a comorbidity assessment instrument.Comparative evaluation of ASA classification and ACE-27 index as morbidity scoring systems in oncosurgeriesRefined comorbidity index based on dimensionality of comorbidity for use in studies of health-related quality of life.Validating a Patient-Reported Comorbidity Measure with Respect to Quality of Life in End-Stage Renal DiseaseMeasurement and impact of co-morbidity in elderly patients with advanced non-small cell lung cancer treated with chemotherapy. A phase II study of weekly paclitaxel.Adaptation and validation of the Charlson Index for Read/OXMIS coded databases.Depression diagnosis and treatment amongst multimorbid patients: a thematic analysis.Laryngeal cancer cost analysis: association of case-mix and treatment characteristics with medical charges.Comparison of comorbidity collection methodsComorbidity assessment in hemodialysis and peritoneal dialysis using the index of coexistent disease.Physical and mental comorbidity of headache in a nationally representative sample of US adults.The significance of comorbidity in advanced laryngeal cancer.Weighted index explained more variance in physical function than an additively scored functional comorbidity scaleThe Benefit of Adjuvant Chemotherapy in Elderly Patients with Stage III Colorectal Cancer is Independent of Age and Comorbidity.The functional comorbidity index had high inter-rater reliability in patients with acute lung injury.Impact of comorbidities by ACE-27 in the revised-IPSS for patients with myelodysplastic syndromes.Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences.Prevalence and comorbidity of diabetes mellitus among non-institutionalized older adults in Germany - results of the national telephone health interview survey 'German Health Update (GEDA)' 2009.Comparison of a disease-specific and a generic severity of illness measure for patients with community-acquired pneumonia.Screening for diabetes in an outpatient clinic population.Chronic disease as a barrier to breast and cervical cancer screening.Weight loss predicts mortality after recurrent oral cavity and oropharyngeal carcinomas.Issues concerning the on-going care of patients with comorbidities in acute care and post-discharge in Australia: a literature review.Association of comorbidities with overall survival in myelodysplastic syndrome: development of a prognostic model.Comorbidity is independently associated with poor outcome in extremity soft tissue sarcoma.Practical considerations in the measurement of outcomes in healthcare.The cost and efficacy of two wound treatments.Trends in a life threatening condition: morbid obesity in dutch, Turkish and Moroccan children in The NetherlandsThe influence of comorbidity and other health measures on dental and medical care use among Medicare beneficiaries 2002Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer.Time-varying impact of comorbidities on mortality after liver transplantation: a national cohort study using linked clinical and administrative data.Comorbidity as a prognostic variable in multiple myeloma: comparative evaluation of common comorbidity scores and use of a novel MM-comorbidity scoreComorbidity Assessment in Skin Cancer Patients: A Pilot Study Comparing Medical Interview with a Patient-Reported Questionnaire.Association between number of comorbid medical conditions and depression among individuals with diabetes; race and ethnic variations.A systematic literature review of life expectancy prediction tools for patients with localized prostate cancerThe impact of comorbidity on outcomes.
P2860
Q24169391-3550CC25-4500-45BE-A5B8-FCD9BAB4A1ECQ24647220-CCBE17F9-804F-4E3D-8E81-CDC675AE5882Q24685958-BFA02738-A379-4198-9B27-823D4FAA3755Q24810468-8CD61858-007D-429D-8F78-00B7C7ED309FQ24813902-64AB8EC1-8FD0-4167-91BA-6101CD55E979Q28749453-E1A69223-3337-4D08-8F78-AA6F8A81FA67Q30276875-26145A3F-7224-4A05-861F-5E1B67968639Q30314487-F4346C59-88C1-4B95-9ABE-4A1DC4BF2F6EQ33374962-F1444B50-1CE4-4BA5-9DF1-05328C91A983Q33522043-8057301F-8F36-4A11-B6AD-3D274889B60EQ33818528-86E0A7FA-9A1E-476C-838D-455F859A425BQ33824066-6A76C8C7-7A63-4BD6-9B51-A713115C1C7EQ33998094-A510890B-5623-4DFD-ABC0-ADF3F6A9769DQ34051264-8A9CF1CC-E780-4690-96E7-51DBCEB06119Q34104184-A82A1963-2AEB-468B-9918-AAAB8B9DDE8CQ34278524-753C928F-FD4D-4F3E-9A8B-56641E3B9766Q34338973-7DEF531D-9135-40D0-92CF-11714BE63C48Q34339987-5B98598B-A6AF-40A1-9E0B-573731D40ED0Q34413956-56E2D021-A86F-48C8-91C1-1BA63005307FQ34457432-03F2764A-C46F-43E5-8100-2026C186F30DQ34583041-6C2A893C-177E-431E-B6A8-985713FEEE52Q34596502-C23C9EC9-5B90-45D8-B714-60C70D05F4C3Q34718727-C16B0D7D-B933-4EDD-B8BE-BD19B948D3C3Q34742745-E3B9145F-3162-40DC-88CA-1B77BCCB5B45Q34751931-6346EA66-C4D2-42BF-B4AF-F4792EEB8A57Q34810844-C52CCDC1-A0C9-47BC-974D-02780B50F758Q34941470-54BC2783-E316-4495-ABFA-B775D8AA9087Q35023414-A7BF8860-F8AE-4C4A-A416-B7449C340AC6Q35086579-B101C609-4C7D-4275-9FAA-67988393969AQ35133295-A6698E2E-6D60-480E-A3AB-C8CB147FD108Q35137156-55B03E91-5730-4FCF-9690-15DEF65962B0Q35147718-8D0147A3-62B4-4B7E-9E8F-EE6DB6385219Q35287878-7D7C05B0-DEA8-4653-8C0D-C647FAC941D7Q35536822-36B91930-D1B8-48C0-AFB4-2C7338400206Q35632387-8C9BB716-A0F9-47B4-8781-F689B4E338D6Q35664302-487743D7-5079-4934-9D6D-318045171982Q35769064-EEFF4D28-580A-4D7D-999E-DBF4E3AB73F9Q35834396-BA2EF409-B957-4B56-9C87-6919A8BD77DCQ35852490-199CCDD9-9826-4185-864E-FEDA6807276EQ35910218-788F641E-34A8-4A97-9987-554FFFD129C2
P2860
The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus.
description
1974 nî lūn-bûn
@nan
1974 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1974 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1974年の論文
@ja
1974年論文
@yue
1974年論文
@zh-hant
1974年論文
@zh-hk
1974年論文
@zh-mo
1974年論文
@zh-tw
1974年论文
@wuu
name
The importance of classifying ...... outcome of diabetes mellitus.
@ast
The importance of classifying ...... outcome of diabetes mellitus.
@en
The importance of classifying ...... outcome of diabetes mellitus.
@nl
type
label
The importance of classifying ...... outcome of diabetes mellitus.
@ast
The importance of classifying ...... outcome of diabetes mellitus.
@en
The importance of classifying ...... outcome of diabetes mellitus.
@nl
prefLabel
The importance of classifying ...... outcome of diabetes mellitus.
@ast
The importance of classifying ...... outcome of diabetes mellitus.
@en
The importance of classifying ...... outcome of diabetes mellitus.
@nl
P1476
The importance of classifying ...... outcome of diabetes mellitus.
@en
P2093
Feinstein AR
P304
P356
10.1016/0021-9681(74)90017-4
P577
1974-09-01T00:00:00Z